FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.
Boellaard
Ronald
R
Department of Nuclear Medicine and PET Research, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. r.boellaard@vumc.nl
O'Doherty
Mike J
MJ
Weber
Wolfgang A
WA
Mottaghy
Felix M
FM
Lonsdale
Markus N
MN
Stroobants
Sigrid G
SG
Oyen
Wim J G
WJ
Kotzerke
Joerg
J
Hoekstra
Otto S
OS
Pruim
Jan
J
Marsden
Paul K
PK
Tatsch
Klaus
K
Hoekstra
Corneline J
CJ
Visser
Eric P
EP
Arends
Bertjan
B
Verzijlbergen
Fred J
FJ
Zijlstra
Josee M
JM
Comans
Emile F I
EF
Lammertsma
Adriaan A
AA
Paans
Anne M
AM
Willemsen
Antoon T
AT
Beyer
Thomas
T
Bockisch
Andreas
A
Schaefer-Prokop
Cornelia
C
Delbeke
Dominique
D
Baum
Richard P
RP
Chiti
Arturo
A
Krause
Bernd J
BJ
D005060:Europe; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis*; D009683:Nuclear Medicine / Q000592:standards*; D049268:Positron-Emission Tomography / Q000592:standards*; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals; D013382:Subtraction Technique / Q000592:standards*; D014057:Tomography, X-Ray Computed / Q000592:standards*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18